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Rare diseases affect up to 6%-8% of the population and pose a challenge to healthcare professionals and healthcare 
system. Hereditary angioedema is a rare life-threatening, debilitating disease characterized by recurrent edema attacks. 
It is essential to establish the diagnosis as quickly as possible. The Healthcare Network was created in order to prevent 
mistreatment of hereditary angioedema. This study evaluated the usefulness of the Hospital Information System and 
the Healthcare Network in urgent management of hereditary angioedema. The Instructions for Hereditary Angioedema 
that contain information on the diagnosis, instructions for treatment, preventive measures prior to a dental procedure, 
endoscopy or surgery under general anesthesia, available regimens and storage location in the Hospital, specialist’s 
telephone number in emergency, and name of the family member to be contacted, were implemented in the Hospital 
Information System, Šibenik General Hospital as a protocol for urgent management. Data on the treatment before and after 
implementation of the Instructions for Hereditary Angioedema were compared. Comparing medical decisions before and 
after implementing the Instructions for Hereditary Angioedema in the Hospital Information System revealed that following 
implementation of the Instructions, correct therapy was administered more often (p=0.006, Fisher exact test) and short-
term prophylaxis applied more often before medical procedures (p=0.011, Fisher exact test). Healthcare Network raised the 
physician awareness of this disabling and potentially fatal disease, led to accurate diagnosis and timely treatment, enabled 
short hospital stay, prompt recovery, and reduced absenteeism from work due to hereditary angioedema. With specifi c 
modifi cations, it could also be extrapolated to other rare diseases.
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Accurate diagnosis and timely treatment of 5000-8000 
known rare diseases that af ect up to 6%-8% of the 
population is a challenge to healthcare professionals 
and system. Around 80% of these diseases are of ge-
netic origin, occur in childhood and persist for life, 
posing considerable burden upon the individuals and 
their families (1). Hereditary angioedema (HAE) is a 
rare, life-threatening, debilitating disease character-
ized by variable clinical presentation of recurrent ede-
ma attacks that can af ect dif erent body regions (2). 
Attacks are usually triggered by infections, trauma or 
stress, by medications such as oral contraceptives with 
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estrogen or angiotensin-converting enzyme (ACE) 
inhibitors, or by procedures such as endoscopies and 
general anesthesia with intubation (3). HAE can pres-
ent as robust abdominal pain leading to unnecessary 
diagnostic (computed tomography scans, laboratory 
tests) and/or exploratory procedures, such as surgery. 
Skin and face swelling may be disi guring or disabling. 
However, life-threatening upper airway obstruction 
is the most troublesome symptom of HAE, especially 
in children with small airway diameter. It can cause 
death by asphyxiation, even at the i rst presenting 
attack (1-3). HAE is an autosomal dominant disease 
caused by mutations in the C1-INH gene, SERPING1 
(4). Low levels of the C1 inhibitor occur in type I C1-
INH-HAE, whereas normal levels of inef ective C1 in-
hibitor cause type II C1-INH-HAE (5-10). h e type of 
HAE in patients with positive family history and nor-
mal C1 inhibitor level and function (nlC1-INH-HAE) 
occurs in a group of patients with a mutation in the 
coagulation factor XII gene (FXII-HAE), or the cause 
of HAE remains unknown (U-HAE) (4). 
In Croatia, HAE ot en remains undiagnosed, which 
leads to inappropriate treatment, mostly with corti-
costeroids and antihistamines that are not ef ective in 
HAE (11,12). In the emergency department (ED) or 
during triggering procedures, it is essential to establish 
the diagnosis as quickly as possible, so that the specii c 
therapy for HAE can be administered to resolve ede-
ma (13). 
h is was the i rst study analyzing the awareness of 
HAE among patients and physicians in Croatia. In ad-
dition, usefulness of the Hospital Information System 
and Healthcare Network in the emergency manage-
ment of HAE was evaluated.
PATIENTS AND METHODS 
h e largest number of clinically well-dei ned HAE pa-
tients were found in the catchment population of the 
only hospital in the Šibenik-Knin County, Croatia. Fif-
teen patients from two families were diagnosed with 
Type I C1-INH-HAE. In 12 of them, the diagnosis was 
substantiated with at least one major clinical presenta-
tion (laryngeal edema, abdominal pain, subcutaneous 
angioedema) and one laboratory criterion (C1 inhib-
itor level). In three asymptomatic patients aged 5, 14 
and 20 years, decreased levels of C1 inhibitor were 
found. All of them share the same mutation in SERP-
ING1 (14). To evaluate the awareness of the C1-INH-
HAE diagnosis among patients and physicians, history 
data were collected from electronic medical records 
available in the Hospital Information System (HIS) 
from 2012 to 2014, before creating the Healthcare Net-
work (HN) and during a 22-month period at er creat-
ing the HN. Also, subsequent treatment introduced by 
physicians was observed. h is study was conducted in 
accordance with the amended Declaration of Helsinki. 
h e study and the creation of the HN were approved 
by the Hospital Ethics Committee and all participants 
or minors’ relatives gave their informed written con-
sent.  
Data collection-Hospital Information System
In 2009, the Šibenik General Hospital, among the 
i rst in Croatia, implemented the HIS (IN2, Zagreb, 
Croatia). HIS supports all aspects of hospital busi-
ness: medical (medical documentation management), 
economic (invoicing), and business (hospital busi-
ness monitoring through reports). h e following in-
formation systems are directly connected to the HIS: 
Business Information System (material and i nancial 
accounting), Laboratory Information System (labo-
ratory test acceptance and validation), and Radiology 
Information System (radiological images acceptance). 
In December of 2014, Instructions for HAE were im-
plemented in a new, improved version of the HIS. h e 
name of each C1-INH-HAE patient was marked with 
a red exclamation mark on the screen at the moment 
of signing up at any work site in the Hospital, thus 
notifying the physician about the patient’s condition. 
h e Instructions contain information on the C1-INH-
HAE diagnosis, instructions for treatment, preventive 
measures prior to a dental procedure, endoscopy or 
surgery under general anesthesia, available regimens 
and storage location in the Hospital, emergency spe-
cialist’s telephone number, and the name of the family 
member to be contacted. h ere is also a warning for 
the physician not to prescribe ACE inhibitors or oral 
contraceptives, as well as a notice of any comorbidities 
such us drug allergy.
To evaluate the awareness of the C1-INH-HAE di-
agnosis among patients and healthcare professionals, 
information given by the patient about the C1-INH-
HAE diagnosis and subsequent treatment by physi-
cians were observed and analyzed in the HIS Archive. 
Data about treatment in the 2012-2014 period were 
compared to data collected during the 22-month peri-
od at er implementation of Instructions for HAE (test 
version in December 2014, permanent version in Jan-
uary 2015). 
 Healthcare network
h e Healthcare Network was created in order to pre-
vent mistreatment of HAE. Patients were educated 
about the nature of their condition and given an iden-
tii cation card with an individual plan of C1-INH-
HAE treatment. To prevent adverse events, a letter 
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containing information and instructions about chil-
dren with C1-INH-HAE was sent to schools and kin-
dergartens. E-mail communication between patients 
and HAE specialist continues on an ongoing basis. h e 
Instructions for HAE were implemented in the Hospi-
tal Information System (HIS), Šibenik General Hospi-
tal. h e benei t of Healthcare Network was evaluated 
by analyzing data in the HIS, i nding data on already 
established C1-INH-HAE diagnosis and treatment of 
HAE attacks.
Statistical analysis
Data were processed by use of the SPSS version 20 
sot ware. Statistical analysis of data was performed us-
ing descriptive statistics. Variables were tested by Fish-
er exact test. h e level of statistical signii cance was set 
at p<0.05.
RESULTS 
Followed by available electronic medical records in 
the HIS (before implementing the Instructions for 
HAE in the HIS) from 2012 to 2014, three of 15 (20%) 
C1-INH-HAE patients visited the Šibenik General 
Hospital Emergency Department (ED) for a total of 12 
HAE attacks. h e main symptom for emergency treat-
ment was abdominal and laryngeal swelling followed 
by facial and skin edema. According to the HIS, only 
one C1-INH-HAE patient who visited ED for HAE at-
tack gave information about the illness, although the 
C1-INH-HAE diagnosis had already been established 
in all of them. h e C1-INH-HAE diagnosis was never 
reported during abdominal edema attack. Short-term 
prophylaxis was not applied on 2 occasions: before 
giving birth and gastroscopy, triggering an abdominal 
edema attack. All patients except for one patient hav-
ing reported diagnosis on two occasions were treated 
with corticosteroids and antihistamines during laryn-
geal edema attacks. Abdominal attacks were treated 
with antibiotics, analgesics, or symptomatic therapeu-
tics. One urgent tracheotomy was performed during 
laryngeal edema attack. During regular visits to physi-
cians for chronic disease follow-up (hypertension, di-
abetes) before creating HN, only 4/15 (20.6%) patients 
informed about the C1-INH-HAE diagnosis. One pa-
tient experienced several massive laryngeal edema at-
tacks during ACE inhibitor therapy for hypertension, 
once ending in urgent tracheostomy. Recognized as 
acute abdomen, one patient was almost subjected to 
laparotomy during an abdominal edema attack before 
the edema spontaneously resolved. Until 2015, esopha-
gogastroduodenoscopy was performed three times 
on the same patient without short-term prophylaxis. 
During pregnancy, one female patient experienced ab-
dominal edema attacks 3 times. Treatment was always 
symptomatic with no evidence of C1-INH-HAE diag-
nosis noticed by her obstetrician. Joint swelling was 
treated in one patient as polyarthralgia with a recom-
mendation of immunology testing for rheumatoid ar-
thritis. One patient experienced massive facial edema 
attack at er a dental-oral procedure. Although she had 
the physician’s letter proving the C1-INH-HAE diag-
nosis and the drug given by her physician to be applied 
in case of a life-threatening swelling, the drug was not 
administered.
Followed by available electronic medical records in 
the HIS (at er implementation of the Instructions for 
HAE), from January 2015 until October 2016, 11/15 
(73%) C1-INH-HAE patients visited a physician in the 
Šibenik General Hospital. Six patients were examined 
for chronic disease follow-up (diabetes, hypertension) 
or acute diseases such as stenocardia or obstructive 
bronchitis, but four of them reported the C1-INH-
HAE diagnosis on 16/29 (55%) occasions. Five pa-
tients visited the ED on seven occasions because of 
a C1-INH-HAE attack, all of them reported the C1-
INH-HAE diagnosis, and appropriate therapy was ap-
plied for 6/7 (85%) attacks. Despite medical history, 
notice to the physician in the HIS and Instructions 
for HAE, abdominal edema attack was misdiagnosed 
as acute gastroenterocolitis and treated erroneously. 
Short-term prophylaxis before dental-oral procedures, 
endoscopies or general anesthesia were undertaken 12 
times in 12 procedures. 
According to the Instructions for HAE implemented 
in the HIS, an anesthesiologist suggested attenuated 
androgen danazol to a patient for 5 days before an op-
eration in spinal anesthesia, and on-demand therapy 
(icatibant) was prepared in case of necessity. Although 
education through Healthcare Network was obtained, 
one patient reported the HAE diagnosis at 4/6 visits to 
a pediatrician for asthma exacerbation. Due to tagging 
in the HIS, management was accurate on all occasions. 
Due to physical exertion, one patient experienced an 
abdominal and skin (hand) edema attack at work. 
Within an hour, on-demand therapy was applied and 
the patient got back to work. 
Comparing medical decisions before and at er imple-
menting HAE instructions through the HIS, correct 
therapy was given more ot en (p=0.006, Fisher exact 
test) and prophylaxis was applied more ot en before 
medical procedures (p=0.011, Fisher exact test). HAE 
diagnosis was not more ot en reported by patient to a 
physician (p=0.045, Fisher exact test) (Table 1).
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Table 1
Dif erences between hospital visits, reported hereditary 
angioedema diagnosis and applied therapy in two observed 
period: before (2012-2014y) and at er (2015-2016y) imple-
mentation of HIS
HIS
No (%) of occasions in HN
p*
2012 – 2014.y 2015 -2016.y Total
No of visits
HAE attack 12/36 (33%) 7/29 (24%) 19/45 (42%)
0.584
Other 24/36 (67%) 22/29 (76%) 26/45 (58%)
Reported HAE diagnosis
Yes 14/36 (39%) 16/29 (55%) 19/45 (42%)
0.219
No 22/36 (61%) 13/29 (45%) 26/45 (58%)
Preventive therapy applied
Yes 0 12/12 (100%) 12/14 (85.8%)
0.011
No 2/2 (100%) 0 2/14 (14.2%)
Emergency therapy
Appropriate 2/12 (16.6%) 6/7 (85,8%) 8/19 (42%)
0.006
Inappropriate 10/12 (83.4%) 1/7 (14.2%) 11/19 (58%)
Values are number of patients. 
* Fisher’s Exact test. Y-years.
HAE - hereditary angioedema
HIS - Hospital Information System 
HN - Healthcare Network
DISCUSSION 
Rare conditions typically remain undiagnosed or 
misdiagnosed, require new approaches and program, 
as proposed by Baynam et al. (15). In an Australian 
study, approximately 30% of patients saw more than 
six physicians before receiving correct diagnosis and 
46% had received at least one incorrect diagnosis (16). 
HAE morbidity and mortality remain considerable 
despite the availability of diagnostic tests and specif-
ic treatments, representing a notable socioeconomic 
burden. HIS analysis also revealed social (unemploy-
ment, isolation) and emotional (avoiding partnership 
or parenthood, trepidation for af ected children) bur-
den, dii  culties in education, and premature retire-
ment of HAE patients, pointing to the need of struc-
tural changes in the healthcare system. As Otani et al. 
suggest, HAE management in emergency departments 
can be improved with a focus on recognition of HAE 
attacks and administration of ef ective therapies (17). 
Protocol for HAE is designed to test whether the In-
structions for HAE implemented in the HIS are more 
ef ective than the usual practice (history i ndings, 
laboratory tests, clinical examination) in the urgent 
management of patients with HAE. To the best of our 
knowledge, a similar IT model for urgent diagnosis of 
rare diseases such as HAE has not yet been established. 
A group of French authors organized the SOS-HAE 
call center for HAE to address the handling of HAE at-
tacks experienced at home (18). Due to the large num-
ber of C1-INH-HAE patients in the Šibenik General 
Hospital (the minimal prevalence in the Šibenik-Knin 
County with approximately 100,000 inhabitants is es-
timated to be 1 per 7500) including tourists, and the 
high frequency of laryngeal edema attacks, improv-
ing the management of HAE patients is needed. HAE 
is ot en misdiagnosed, which leads to inappropriate 
pharmacological therapies, thus potentially expos-
ing the patients with laryngeal attacks to the risk of 
asphyxiation (14-19). h e low rate of HAE diagnosis 
reported by patients with already established C1-INH-
HAE in this study indicated the lack of awareness of 
HAE as a serious disease among HAE patients. Educa-
tion through the Healthcare Network has insui  cient-
ly raised the awareness of HAE among patients, thus 
making the implementation of the Instructions for 
HAE in the HIS even more important. Before tagging 
in the HIS, all involved HAE patients except for one 
were treated with glucocorticoids and antihistamines 
for laryngeal edema, which are inef ective in HAE 
(21). In Croatia, specii c therapeutics such as plas-
ma-derived C1-INH, recombinant C1-INH and a bra-
dykinin receptor B2 antagonist icatibant have recently 
been available for the treatment of acute HAE attacks 
and for short-term prophylaxis (plasma-derived C1-
INH) before triggering procedures. Instructions for 
HAE implemented in the HIS have improved manage-
ment during angioedema attacks, especially abdom-
inal and laryngeal, raised the physician awareness of 
this disabling and potentially fatal disease, led to ac-
curate diagnoses and timely treatment, enabled short 
hospital stay, prompt recovery, and reduced work and 
school absenteeism for HAE patients, thus highly im-
proving their quality of life. h ese encouraging i nd-
ings prompted a group of experts for HAE manage-
ment in Croatia to recommend implementation of this 
model in the information systems of other hospitals 
(11). Studies analyzing the economic costs associated 
with acute attacks and long-term management of HAE 
estimated the total annual per patient cost at $42,000 
for the average HAE patient (21). Further investiga-
tions should be conducted to analyze the implications 
of the Instructions for HAE implemented in hospital 
information systems compared to education costs for 
healthcare professionals in terms of socioeconomic 
costs for both healthcare services and patients. 
CONCLUSIONS 
h e need for high level of knowledge and appreciation 
of rare diseases among patients and physicians has 
been noted. h e Healthcare Network and the HIS have 
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improved the management of HAE and prevented ad-
verse events. With specii c modii cations, it could eas-
ily be implemented for other rare diseases, since they 
all share the same challenge.
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Rijetke bolesti su izazov zdravstvenim stručnjacima i sustavima. Smatra se da 6-8 % populacije boluje od rijetkih bolesti. 
Nasljedni angioedem (HAE) jedna je od rijetkih bolesti, karakterizirana ponavljajućim napadima oteklina (edema) različitih 
dijelova tijela te se vrlo često ne dijagnosticira pravodobno, a težina ponavljajućih napadaja se pogoršava i za život je 
opasno stanje. Bitno je posumnjati na rijetku bolest i postaviti dijagnozu što je brže moguće. Ova je probna studija procijenila 
korisnost implementacije podataka o bolesnicima s HAE u Bolnički informacijski sustav (BIS) Opće bolnice Šibensko-
kninske županije kao i primjenu protokola za hitno zbrinjavanje i formiranje mreže zdravstvene zaštite (MZZ). Upute u BIS-u 
za HAE sadrže podatke o dijagnozi HAE-a, upute za liječenje, preventivne mjere prije stomatološkog, endoskopskog ili 
kirurškog postupka (pod lokalnom/općom anestezijom); popis raspoloživih lijekova u hitnoći i mjesto njihove pohrane u 
bolnici; telefonski broj specijalista u hitnoći te ime člana obitelji (kontakt osoba). Podatci o liječenju prije primjene uputa za 
HAE uspoređeni su s podatcima prikupljenima u razdoblju nakon provedbe implementacije novog sustava. Uspoređujući 
medicinske odluke prije i nakon implementacije uputa za HAE u BIS-u, pravilna je terapija bila češće primijenjena (p = 
0,006, Fisherov test), kao i kratkotrajna profi laksa prije medicinskih postupaka (p = 0,011, Fisherov test). Uspostava MZZ 
pospješuje informiranost medicinskog osoblja, pravilan odabir liječenja i zbrinjavanje bolesnika s HAE. Omogućuje brži 
oporavak, kraći boravak u bolnici i smanjenje radne odsutnosti bolesnika s HAE. Temeljem ove studije otvara se mogućnost 
primjene MZZ i za druge rijetke bolesti.
Ključne riječi: nasljedni angioedem, hitna pomoć, implementacija uputa
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